Dr. Ford Brewer MD MPH · 2026-04-23 · Ford Brewer (host), Jesus Vega
The Real Reason Statins Are Overprescribed
32 research-tied claims examined: 3 contradicted 3 overstated 4 context 18 supported 4 unverified
4 No source found (not proven false)
The Honda study shows that individuals with stable calcified plaque have approximately the same cardiovascular event risk as individuals with no plaque.
"even though you look at studies like the Honda study, which shows that people with stable plaque really have about the same risk as somebody with no plaque." (said at 0:24:50)
No published record matching the claim that the "Honda study" demonstrated individuals with stable calcified plaque have approximately the same cardiovascular event risk as individuals with no plaque was located; this does not prove the claim false. While cardiovascular literature extensively examines coronary artery calcification, plaque morphology, and subsequent event risk, no study authored by Honda or commonly referred to as the Honda study showing identical risk between calcified plaque and absence of plaque was identified.
High-dose atorvastatin increases insulin resistance by 8% to 24% within several weeks in patients without changes in diet or weight, as measured by euglycemic hyperinsulinemic clamp.
"Now, when you use that test, researchers found a couple of things. One, that high-dose atorvastatin—Lipitor, which is the brand name—it increased insulin resistance by 8 to 24% in just a few weeks. So, there was no change in diet, no change in weight in these patients." (said at 0:49:45)
No published record matching the claim that high-dose atorvastatin increases insulin resistance by 8% to 24% within several weeks as measured by euglycemic hyperinsulinemic clamp in patients without changes in diet or weight was located; this does not prove the claim false.
Statins exhibit pleiotropic anti-inflammatory effects that reduce C-reactive protein, Lp-PLA2, and the urine microalbumin-creatinine ratio, and promote plaque stabilization.
"Statins have what we call pleiotropic effects... in statins, that means uh you get an impact on inflammation. And so, what we're really interested in is what they actually do: C-reactive protein reduction in this case, inflammation, uh Lp-PLA2, microalbumin-creatinine uh ratio, plaque stabilization." (said at 1:10:52)
No published record matching the claim that statins exhibit pleiotropic anti-inflammatory effects that reduce C-reactive protein, Lp-PLA2, and the urine microalbumin-creatinine ratio, and promote plaque stabilization was located; this does not prove the claim false.
Low doses of statins are sufficient to impact vascular inflammation, lower CRP, improve endothelial function, and stabilize arterial plaque without needing high or moderate doses.
"So, what we're looking for is low-dose statins because the low-dose statins actually impact You don't need a high dose or even a mid dose to impact vascular inflammation, that CRP, that microalbumin-creatinine ratio. And what we're looking for is stabilization of the plaque." (said at 1:13:55)
No published record matching the claim that low-dose statins are sufficient to impact vascular inflammation, lower hs-CRP, improve endothelial function, and stabilize arterial plaque without needing moderate or high doses was located; this does not prove the claim false.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.